COVID-19 Resources
Stay in Touch!
COMMUNITY ENGAGEMENT CORE OVERVIEW
NJACTS draws leading academic, industry and community groups together to understand and address the health needs of New Jersey. Central to this is engagement with our community to ensure that our efforts respond to their priorities. Our goal is to conduct research with the New Jersey community, in the community and for the community, and yet, have impact beyond our state’s boundaries.
Community Blog
Rutgers Pediatrician Discusses How to Keep Children Safe at School
As more New Jersey school districts face COVID-19 outbreaks and some are forced to stop in-person classes, many health care experts worry about what to expect as we head into the flu season. Pediatrician Lawrence Kleinman, professor, vice chair for academic...
Health officials urge Americans to get flu vaccine as concerns mount over possible ‘twindemic’
Amid the coronavirus pandemic, health care experts have been urging Americans to get vaccinated against influenza during the 2020-2021 flu season, to prevent a "twindemic," overlapping epidemics of the flu and COVID-19, which could overwhelm hospitals and increase...
‘We’ve been forgotten’: In Newark, N.J., a toxic Superfund site faces growing climate threats
In the bewildering days after Superstorm Sandy roiled the Eastern seaboard in October 2012, shredding coastal communities with hurricane-force winds and once-in-a-generation flooding, Ana Baptista ventured into the Ironbound, an industrial neighborhood of...
Developing the Mentor: How Do I Know What to Do?
This Rutgers Biomedical and Health Sciences program will inform you how to develop effective mentoring relationships and articulate your mentoring philosophy. Presenters: Anita Siu, Pharm.D., BCPPS Clinical Professor Ernest Mario School of Pharmacy Andrew Gow, PhD...
How we get people to trust science
In this election season, the value of science, its methods, and results are increasingly questioned by many political leaders and some segments of the public. We’ve all collectively benefited from the many scientific advancements over the years, so why are there...
NIH begins a large Phase 3 clinical trial to test immune modulators for the treatment of COVID-19
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines...